Pioglitazone and metformin (Cambridge Therapeutics Technologies, LLC)
Welcome to the PulseAid listing for the Pioglitazone and metformin drug offered from Cambridge Therapeutics Technologies, LLC. This Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator Receptor gamma Agonist [EPC],Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR alpha [Chemical/Ingredient],PPAR gamma [Chemical/Ingredient],Thiazolidinedione [EPC],Thiazolidinediones [Chemical/Ingredient],Biguanide [EPC],Biguanides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Cambridge Therapeutics Technologies, LLC |
| NON-PROPRIETARY NAME: | Pioglitazone and metformin |
| SUBSTANCE NAME: | PIOGLITAZONE HYDROCHLORIDE; METFORMIN HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator Receptor gamma Agonist [EPC],Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR alpha [Chemical/Ingredient],PPAR gamma [Chemical/Ingredient],Thiazolidinedione [EPC],Thiazolidinediones [Chemical/Ingredient],Biguanide [EPC],Biguanides [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2013-05-02 |
| END MARKETING DATE: | 0000-00-00 |
Pioglitazone and metformin HUMAN PRESCRIPTION DRUG Details:
| Item Description | Pioglitazone and metformin from Cambridge Therapeutics Technologies, LLC |
| LABELER NAME: | Cambridge Therapeutics Technologies, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 15; 500(mg/1; mg/1) |
| START MARKETING DATE: | 2013-05-02 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 70882-105_e083276f-e247-4e50-a279-5b9f2923df71 |
| PRODUCT NDC: | 70882-105 |
| APPLICATION NUMBER: | ANDA091273 |
Other PIOGLITAZONE HYDROCHLORIDE; METFORMIN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
